Zynex (NASDAQ:ZYXI – Get Free Report) had its price objective lowered by equities researchers at HC Wainwright from $17.00 to $15.00 in a research note issued on Wednesday,Benzinga reports. The ...

Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) investors concerning the Company's possible violations of federal ...

Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...

Fintel reports that on March 12, 2025, RBC Capital downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Outperform to ...

The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) on behalf of investors concerning the Company's possible violations of federal ...

Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...

Zynex (ZYXI) stock drops as RBC Capital Market downgrades following the company's Q4 2024 earnings report. Read more here.

Ladenburg downgraded Zynex (ZYXI) to Neutral from Buy without a price target saying the company continues to adjust operationally amid revenue ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ICU Medical (ICUI – Research Report) and ...

Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic ...

Finance of America swung to a loss in the fourth quarter because of higher income expenses. The mortgage loan provider posted a loss of $5.95 a share, compared with a profit of $5.35 a share the year ...